An ultra‐low‐cost smartphone octochannel spectrometer for mobile health diagnostics

With the rapid development and proliferation of mobile devices with powerful computing power and the ability of integrating sensors into mobile devices, the potential impact of mobile health (mHealth) diagnostics on the public health is drawing researchers' attention. We developed a Smartphone Octo-channel Spectrometer (SOS) as a mHealth diagnostic tool. The SOS has nanoscale wavelength resolution, is self-illuminated from the smartphone itself, and is ultra-low cost (less than $20). A user interface controls the optical sensing parameters and precise alignment. After calibrating and testing the SOS by quantifying protein concentrations, we clinically validated the SOS by comparing the diagnostic performance of our device with that of a clinical spectrophotometer. About 180 serum samples from de-identified patients with 4 types of autoantibodies were blindly read the ELISA results. The accuracy of the SOS achieved 100% across the clinical reportable range compared with the FDA-approved instrument. Furthermore, the self-illuminated SOS only requires about half of the light intensity of the FDA-approved instrument to achieve clinical-level sensitivity. The low-energy-consumption and low-cost SOS enables point-of-care spectrophotometric sensing in low-resource areas, and can be integrated into point-of-care diagnostic systems for rapid multiplex readout and analysis at patient bedside or at home.

[1]  B. Amor,et al.  Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA). , 1978, Annals of the rheumatic diseases.

[2]  Steve Feng,et al.  Cellphone-Based Hand-Held Microplate Reader for Point-of-Care Testing of Enzyme-Linked Immunosorbent Assays. , 2015, ACS nano.

[3]  G. Hughes,et al.  Serological markers in progressive systemic sclerosis: clinical correlations. , 1983, Annals of the rheumatic diseases.

[4]  S. Whittingham,et al.  A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis. , 1986, Journal of immunology.

[5]  A. Haines,et al.  The Effectiveness of Mobile-Health Technologies to Improve Health Care Service Delivery Processes: A Systematic Review and Meta-Analysis , 2013, PLoS medicine.

[6]  J. Koziol,et al.  Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.

[7]  N. Rose,et al.  Women and Autoimmune Diseases , 2004, Emerging infectious diseases.

[8]  P. Mortensen,et al.  Pregnancy and the Risk of Autoimmune Disease , 2011, PloS one.

[9]  Yu-Chung Chang,et al.  High-Throughput Optical Sensing Immunoassays on Smartphone. , 2016, Analytical chemistry.

[10]  A Kavanaugh,et al.  Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. , 2000, Archives of pathology & laboratory medicine.

[11]  Aydogan Ozcan,et al.  Highly Stable and Sensitive Nucleic Acid Amplification and Cell-Phone-Based Readout. , 2017, ACS nano.

[12]  Borja Martínez-Pérez,et al.  Mobile Health Applications for the Most Prevalent Conditions by the World Health Organization: Review and Analysis , 2013, Journal of medical Internet research.

[13]  D. Isenberg,et al.  Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study , 2009, Arthritis research & therapy.

[14]  L. Aarden,et al.  Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[15]  P. Fox Autoimmune Diseases and Sjögren's Syndrome , 2007, Annals of the New York Academy of Sciences.

[16]  Yu-Chung Chang,et al.  Smartphone Optosensing Platform Using a DVD Grating to Detect Neurotoxins , 2016 .

[17]  Lingqian Chang,et al.  Nanoscale bio-platforms for living cell interrogation: current status and future perspectives. , 2016, Nanoscale.

[18]  J. Nelson,et al.  Autoimmune Disease During Pregnancy and the Microchimerism Legacy of Pregnancy , 2008, Immunological investigations.

[19]  M. Reichlin ANA negative systemic lupus erythematosus sera revisited serologically , 2000, Lupus.

[20]  N. Rose,et al.  Sex differences in autoimmune disease from a pathological perspective. , 2008, The American journal of pathology.

[21]  Steve Feng,et al.  High-throughput and automated diagnosis of antimicrobial resistance using a cost-effective cellphone-based micro-plate reader , 2016, Scientific Reports.

[22]  H. Ren,et al.  Simultaneous Positivity for Anti-DNA, Anti-Nucleosome and Anti-Histone Antibodies is a Marker for More Severe Lupus Nephritis , 2012, Journal of Clinical Immunology.

[23]  E. Tan,et al.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. , 1989, Advances in immunology.

[24]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[25]  Yu-Chung Chang,et al.  A multichannel smartphone optical biosensor for high-throughput point-of-care diagnostics. , 2017, Biosensors & bioelectronics.

[26]  J. Sánchez-Guerrero,et al.  Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[27]  Tairong Kuang,et al.  Molecular Beacon Nano-Sensors for Probing Living Cancer Cells. , 2017, Trends in biotechnology.

[28]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.